In vitro time-kill pharmacodynamics of telithromycin against macrolide resistant pneumococcal isolates harbouring ribosomal mutations

被引：0
|
作者：
Al-Lahham, A
Barbosa, SD
Lütticken, R
Reinert, RR
机构：
[1] NRCS, Aachen, Germany
[2] Univ Hosp, Inst Med Microbiol, Aachen, Germany
来源：
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY | 2004年 / 294卷
关键词：
D O I：
暂无
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
下载
收藏
页码：177 / 178
页数：2
相关论文
共 50 条
  • [1] Evaluation of telithromycin against Streptococcus pneumoniae with ribosomal mutations utilizing in vitro time-kill methodology
    Dandekar, PK
    Tessier, PR
    Farrell, DJ
    Nightingale, CH
    Nicolau, DP
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 (04) : 331 - 334
  • [2] Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22
    Reinert, RR
    Al-Lahham, A
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (07) : 3011 - 3013
  • [3] Comparative in vitro and bactericidal activities of telithromycin against penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant Streptococcus pneumoniae by time-kill methodology
    Kays, Michael B.
    Lisek, Christopher R.
    Denys, Gerald A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 (03) : 289 - 294
  • [4] Bactericidal activity of telithromycin against penicillin-nonsusceptible, macrolide-resistant, and levofloxacin-resistant Streptococcus pneumoniae by time-kill methodology
    Kays, MB
    Lisek, CR
    PHARMACOTHERAPY, 2004, 24 (10): : 1443 - 1443
  • [5] In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States
    Green, M
    Allen, C
    Bradley, J
    Dashefsky, B
    Gilsdorf, JR
    Marcon, MJ
    Schutze, GE
    Smith, C
    Walter, E
    Martin, JM
    Edwards, KA
    Barbadora, KA
    Rumbaugh, RM
    Wald, ER
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (06) : 2487 - 2489
  • [6] Time-kill studies of Synercid(TM) against vancomycin-resistant and endophthalmitis isolates of Enterococcus
    Warren, BB
    Kowalski, RP
    Eller, AW
    Friberg, TR
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 3554 - 3554
  • [7] Disposition of oral telithromycin in foals and in vitro activity of the drug against macrolide-susceptible and macrolide-resistant Rhodococcus equi isolates
    Javsicas, L. H.
    Giguere, S.
    Womble, Ariel Y.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2010, 33 (04) : 383 - 388
  • [8] In vitro time-kill analysis of oritavancin against clinical isolates of methicillin-resistant Staphylococcus aureus with reduced susceptibility to daptomycin
    Vidaillac, Celine
    Parra-Ruiz, Jorge
    Rybak, Michael Joseph
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2011, 71 (04) : 470 - 473
  • [9] In vitro activities of telithromycin, linezolid, and quinupristin-dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations
    Farrell, DJ
    Morrissey, I
    Bakker, S
    Buckridge, S
    Felmingham, D
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (08) : 3169 - 3171
  • [10] In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates
    Peck, Kyong Ran
    Kim, Min Ja
    Choi, Ji Young
    Kim, Hong Sun
    Kang, Cheol-In
    Cho, Yong Kyun
    Park, Dae Won
    Lee, Hee Joo
    Lee, Mi Suk
    Ko, Kwan Soo
    JOURNAL OF MEDICAL MICROBIOLOGY, 2012, 61 (03) : 353 - 360
12345